Vimarsana
Biggest News Aggregation in the World

Quest Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quest Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quest Pharmaceuticals Today - Breaking & Trending Today

Appeals Court Rules Insurers Not Obligated to Defend Opioid Distributor McKesson - Vimarsana News

Appeals Court Rules Insurers Not Obligated to Defend Opioid Distributor McKesson

The role drug distributor McKesson Corp. had in the opioid crisis was no accident, meaning the company is not entitled to defense costs related to

Chandra Dhakal Assumes The Responsibility Of New FNCCI President | New Spotlight Magazine - Vimarsana News

Chandra Dhakal Assumes The Responsibility Of New FNCCI President | New Spotlight Magazine

Chandra Dhakal Assumes The Responsibility Of New FNCCI President

Anjan, Ram Chandra And Umesh Lal To Contest For FNCCI's Senior Vice President - Vimarsana News

Anjan, Ram Chandra And Umesh Lal To Contest For FNCCI's Senior Vice President

Anjan, Ram Chandra And Umesh Lal To Contest For FNCCI’s Senior Vice President

No CGL Coverage for Opioid Distributor Sued for Economic Damages but Not Bodily Injury Damage | Carlton Fields - Vimarsana News

No CGL Coverage for Opioid Distributor Sued for Economic Damages but Not Bodily Injury Damage | Carlton Fields

In Westfield National Insurance Co. v. Quest Pharmaceuticals, the Sixth Circuit held that two insurers owed no coverage obligations to Quest Pharmaceuticals in connection with 77...

Quest PharmaTech announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American Association of Clinical Oncologists - Vimarsana News

Quest PharmaTech announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American Association of Clinical Oncologists

Share this article TSX Venture: QPT                                                                      EDMONTON, AB, June 1, 2021 /PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that clinical investigators working with OncoQuest Pharmaceuticals, Inc. ("OQP") lead clinical candidate oregovomab, will be making two presentations as part of the American Society of Clinical Oncology (ASCO) conference proceedings. OQP acquired oregovomab from OncoQuest Inc., one of the equity investee comp...